Curaleaf (OTCMKTS:CURLF) Lowered to Hold Rating by Atb Cap Markets

Atb Cap Markets cut shares of Curaleaf (OTCMKTS:CURLF) from a strong-buy rating to a hold rating in a report published on Thursday morning,Zacks.com reports.

Several other brokerages also recently commented on CURLF. Cormark raised shares of Curaleaf from a “hold” rating to a “moderate buy” rating in a research note on Friday, August 8th. Canaccord Genuity Group raised shares of Curaleaf to a “strong-buy” rating in a report on Thursday, October 9th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Curaleaf has an average rating of “Buy”.

Curaleaf Stock Performance

OTCMKTS CURLF opened at $2.43 on Thursday. Curaleaf has a 52-week low of $0.68 and a 52-week high of $3.65. The company has a fifty day moving average of $2.86 and a 200-day moving average of $1.83. The company has a market capitalization of $1.63 billion, a P/E ratio of -7.59 and a beta of 0.71. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.70 and a current ratio of 1.47.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 19.50% and a negative return on equity of 15.54%. As a group, equities research analysts predict that Curaleaf will post -0.25 EPS for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.